Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study. - Wikidata - awgldk - TriplyDB

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.

http://www.wikidata.org/entity/Q30682187

about

Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement Novel Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis Cervical cancer prevention in Australia: Planning for the future Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer.Genital human papillomavirus infection among women in Bangladesh: findings from a population-based survey Human papillomavirus vaccination: the population impact.Educational interventions to increase HPV vaccination acceptance: a systematic review.The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents.Laser capture microdissection as a tool to evaluate human papillomavirus genotyping and methylation as biomarkers of persistence and progression of anal lesions Evaluation of safety and immunogenicity of a quadrivalent human papillomavirus vaccine in healthy females between 9 and 26 years of age in Sub-Saharan Africa Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention.Thank You, Edward. Merci, Louis Associations Between Exposure to and Expression of Negative Opinions About Human Papillomavirus Vaccines on Social Media: An Observational Study The impact of HPV vaccination on future cervical screening: a simulation study of two birth cohorts in Denmark.Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012.Transitioning from cytology-based screening to HPV-based screening at longer intervals: implications for resource use.Attitudes, Knowledge and Factors Associated with Human Papillomavirus (HPV) Vaccine Uptake in Adolescent Girls and Young Women in Victoria, Australia Determinants of geographic inequalities in HPV vaccination in the most populated region of France.Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009-2013.Study of 2 years follow-up of referral patients with abnormal Pap smear US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines Parents' and providers' attitudes toward school-located provision and school-entry requirements for HPV vaccines Less than 3 doses of the HPV vaccine - Review of efficacy against virological and disease end points.Why don't adolescents finish the HPV vaccine series? A qualitative study of parents and providers.Comparing human papillomavirus vaccine knowledge and intentions among parents of boys and girls.An exploration of individual- and population-level impact of the 2-dose HPV vaccination schedule in pre-adolescent girls Effect of human papillomavirus vaccination on cervical cancer screening in Alberta.Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study Endocervical Carcinogenesis and HPV Vaccination: An Occasional Circumstance or a Gap in the Chain?Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia.Declines in HPV-associated high-grade cervical lesions after introduction of HPV vaccines in Connecticut, US, 2008-2015.Potential of the quadrivalent human papillomavirus vaccine in the prevention and treatment of cervical cancer.Human papillomavirus vaccination: where are we now?Factors impacting HPV vaccination: lessons for health care professionals.Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (gardasil(®)): a review of its use in the prevention of premalignant anogenital lesions, cervical and anal cancers, and genital warts.Cervical cancer screening at crossroads.Recent progress in vaccination against human papillomavirus-mediated cervical cancer.Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.

P2860

Q28069669-4E894FEE-499B-4A03-81BA-AA50E153704D Q28071998-517AB235-6CBC-4914-863D-80CE18CF224F Q28081927-D8258119-5905-489E-B2E2-EE95F83E2E25 Q28084924-3CD53454-2EAF-4E90-BDEC-93555D170093 Q28270412-AB5DF15B-88EF-47DF-A94B-E09FC3E6EFFD Q30301333-4A83EAE0-BA1A-475E-8C7E-C09F891190D5 Q30856793-9D46AEB1-8477-4B39-B3AD-CA4F1A5638E5 Q33806566-B6D79C8F-CD32-4361-AF3A-348EDF85E389 Q34846745-B24230E5-C354-4594-88D6-DC1C3C676AA5 Q35078557-0581D24B-79B9-4A5E-BF31-D536C7F6059D Q35756579-3948F56A-7661-4046-9ADE-453CF70640E0 Q35887646-12FD5C59-E3AB-46F6-9DAD-A221A0CF0B06 Q35888255-555B1C65-8E56-4870-A0CF-65D068EF6F13 Q35893932-19AA3CEF-65D5-4FBB-8355-2FDC0A3B3A4E Q35922347-1EB6A087-274F-40A3-BCA4-1819F734280C Q35959884-457FAEFC-34DE-477A-A360-605C8193CD9B Q35997434-528F9904-AD1D-4A14-A5CE-1D71502ACBB5 Q35998533-C8F45ABA-D8DF-42BE-AD1E-C5759BDDBD0F Q36114121-012B643E-F26F-4EA9-A156-5C5CA0D4C29E Q36296590-8DBC9F5A-D9E6-430C-B225-E51DDB8E0BD0 Q36418117-6A7050D7-358E-44EB-9DFA-F1125A60436D Q36616813-E4CC136B-70E5-4F07-A962-E1E92FBE9907 Q36817074-DEF6A060-8B98-4DFA-B9C2-E0685A63BB8D Q37134945-DC957DAB-5151-4B8E-ACD0-BD122A4627CC Q37135074-9CFF7510-ABFD-4526-B405-C20AAC1DD7FB Q37135197-D1D68B22-39CF-4B8F-A569-8CF80DB45802 Q37135216-1A37C61D-A02F-4C7F-B428-02DF49FE7A11 Q37135276-9722B5F6-AB76-471B-8585-872D1DF4D6FE Q37227066-D76FAEFD-2366-45D8-9469-8F6174E1706B Q37349077-97A228DE-C535-431F-A70F-46227F4CEEF5 Q37587340-BF860F26-88CB-4759-ABC9-1899C6CA8338 Q37616577-760499DC-1B11-4DB6-9EB6-E48828A0DB06 Q37834158-64697C7A-7227-4F57-B862-E39B40C51E2C Q38182714-C1881140-FEA9-4E4A-89B4-47E695B884C1 Q38218612-DE811BA3-250E-4235-952A-EBE2B7F61613 Q38223242-1FEB7DDA-9AA6-4C5F-B88F-38BB2C179900 Q38229304-0484B759-3405-4AE5-AB33-22539DF1C8EA Q38232145-AB06ED40-253B-48B5-B02E-5FFA271D30B8 Q38370782-6F434489-7D44-42BA-B373-78F965CB869F Q38373388-D2D789F8-E5B1-4553-8C6F-37033BFD0064

P2860

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.

http://www.wikidata.org/entity/Q30682187

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Impact of a population-based H ...... alities: a data linkage study.

@ast

Impact of a population-based H ...... alities: a data linkage study.

@en

type

label

Impact of a population-based H ...... alities: a data linkage study.

@ast

Impact of a population-based H ...... alities: a data linkage study.

@en

prefLabel

Impact of a population-based H ...... alities: a data linkage study.

@ast

Impact of a population-based H ...... alities: a data linkage study.

@en

P1433

Q30682187-3DAD83AA-4184-4FE0-87AC-7C46695171DC

P1476

Q30682187-75FA727D-1F8B-4442-9842-B4EE59AB9C9F

P2093

Q30682187-2FDBAE02-3C88-45F2-87FF-2923330BF628

Q30682187-4A0D0C0D-A7ED-460B-92BD-CCFEB3940708

Q30682187-8714548D-10E8-4447-90E3-6346595037F7

Q30682187-97D17563-9C44-4C40-BB5F-DA9D46899878

Q30682187-B39E4EFA-AEC6-4D9C-8534-5D78685B8152

Q30682187-F71278E7-E9A1-40F9-A695-E2601BA6A6E9

P2860

Q30682187-04557A9D-3B30-4192-9382-935DF21F480B

Q30682187-162CCD8D-BB61-4960-B348-364CB0628DBC

Q30682187-18499048-6774-41A7-8FC4-2D8F99EA3574

Q30682187-2F2C1560-9FB2-4A3C-BC62-A34147D86AB7

Q30682187-30DA2312-EC6C-4C22-BA5B-869BEBC19105

Q30682187-31EADC8E-96B7-4CB5-BF6F-E22DDC5EAC94

Q30682187-3485BD33-9FD3-4641-B5BC-25EC97507427

Q30682187-35B7BF0D-9273-40D5-B430-509609E0E6C4

Q30682187-362C0413-DDFE-4E33-92B8-FF81FB4C9203

Q30682187-5E3FCDFD-119C-4F87-9DF8-345CB112920E

P2888

Q30682187-48E9F8EC-A477-4712-933A-AB4398E2FB76

P304

Q30682187-D4E569C0-9929-46CD-B055-5F602234B171

P31

Q30682187-922A0732-E3A3-40A0-9E74-80B6E83DB7D2

P356

Q30682187-2719B865-96DB-4FB0-AE4B-73BE56440245

P407

Q30682187-86F00BFF-0F37-4E1E-8B4D-5A20A3613644

P478

Q30682187-A2ABC87E-CFB2-4254-A495-EA278621197C

P577

Q30682187-53B2FA15-99A5-4CBF-A549-8DD0FFE722B0

P5875

Q30682187-FB0354E3-B041-4468-8DDC-8DE25D099555

P6179

Q30682187-8297B44B-0B64-490B-BD30-91D0DFF771FC

P698

Q30682187-42AD793A-C70B-4730-8168-0802657C7004

P932

Q30682187-82C07AA3-4141-4B95-BD7C-081830A357C1

P356

1741-7015-11-227

P1433

P1476

Impact of a population-based H ...... alities: a data linkage study.

@en

P2093

A Marion Saville

http://www.w3.org/2001/XMLSchema#string

Alison C Budd

http://www.w3.org/2001/XMLSchema#string

Dorota M Gertig

http://www.w3.org/2001/XMLSchema#string

Genevieve Chappell

http://www.w3.org/2001/XMLSchema#string

Julia M L Brotherton

http://www.w3.org/2001/XMLSchema#string

Kelly Drennan

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.

Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3

Development and validation of reporting guidelines for studies involving data linkage.

Catching up with the catch-up: HPV vaccination coverage data for Australian women aged 18-26 years from the National HPV Vaccination Program Register.

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial.

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial.

Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial.

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer.

P2888

1741-7015-11-227

P304

227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1741-7015-11-227

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258034568

http://www.w3.org/2001/XMLSchema#string

P6179

1037281520

http://www.w3.org/2001/XMLSchema#string

P698

24148310

http://www.w3.org/2001/XMLSchema#string

P932

4015688

http://www.w3.org/2001/XMLSchema#string